Assessment of monocarboxylate transporters 1 and 4, CD147, CD44 and MDRI could help to predict biochemical recurrence in prostate cancer uri icon

autores

  • Pértega-Gomes N
  • Vizcaíno JR
  • Lopes C
  • Baltazar, Fátima

data de publicação

  • abril 1, 2011